Raphaël de Coninck will be speaking at a seminar on recent antitrust developments in the pharmaceutical sector. Details are available here.
Antitrust implications of the build vs. buy playbook in the AI era
The rapid growth of artificial intelligence (AI) makes the build-versus-buy question particularly important. AI markets are evolving quickly, and firms must...
